Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
P
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
ATHEX:PAP
|
GR |
|
T
|
Thomson Reuters Corp
F:TOCB
|
CA |
Intrinsic Value
The intrinsic value for
Capricor Therapeutics Inc (CAPR) under the Base Case is 39.7172 USD.
Compared with the current market price of 8.8423 USD, the stock appears
Undervalued by 78% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Capricor Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Capricor Therapeutics Inc
Earnings Waterfall
Capricor Therapeutics Inc
The intrinsic value for
Capricor Therapeutics Inc (CAPR) under the Base Case is 39.7172 USD.
Compared with the current market price of 8.8423 USD, the stock appears Undervalued by 78% .